Elisabeth I. Heath
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, Hormonal and reproductive studies, PARP inhibition in cancer therapy, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Integrative Clinical Genomics of Advanced Prostate Cancer(2015)3,599 cited
- → Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3(2016)1,550 cited
- → Genomic correlates of clinical outcome in advanced prostate cancer(2019)1,365 cited
- → Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy(2019)609 cited
- → Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer(2018)590 cited
- → Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients with Cancer(2016)469 cited
- → EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma(2020)315 cited
- → The current state of molecular testing in the treatment of patients with solid tumors, 2019(2019)258 cited
- → Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial(2021)255 cited